Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Eskens F"'
Autor:
Simonelli, M., Garralda, E., Eskens, F., Gil-Martin, M., Yen, C.-J., Obermannova, R., Chao, Y., Lonardi, S., Melichar, B., Moreno, V., Yu, M.-L., Bongiovanni, A., Calvo, E., Rottey, S., Machiels, J.-P., Gonzalez-Martin, A., Paz-Ares, L., Chang, C.-L., Mason, W., Lin, C.-C., Reardon, D.A., Vieito, M., Santoro, A., Meng, R., Abbadessa, G., Menas, F., Lee, H., Liu, Q., Combeau, C., Ternes, N., Ziti-Ljajic, S., Massard, C.
Publikováno v:
In ESMO Open October 2022 7(5)
Autor:
Tabernero, J., van Geel, R., Guren, T., Yaeger, R., Spreafico, A., Faris, J., Yoshino, T., Yamada, Y., Kim Tae, W., Bendell, J., Schuler, M., Lenz, H.-J., Eskens, F., Desai, J., Hochster, H., Avsar, E., Demuth, T., Sandor, V., Elez, E., Schellens, J.
Publikováno v:
In Annals of Oncology June 2016 27 Supplement 2:ii127-ii127
Autor:
Veenendaal L, Valk G, Klümpen H, Lolkema M, Dercksen M, Cuppen E, Werken Hvd, Mostert B, Sleijfer S, Riet Jv, Eskens F, Tesselaar M
Metastatic neuroendocrine neoplasms (mNEN) form clinically and genetically heterogeneous malignancies, characterized by distinct prognoses based upon primary tumor localization, functionality, grade, proliferation index and diverse outcomes to treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcf09b131bb3597d86d0b449ed894fbd
https://doi.org/10.21203/rs.3.rs-50333/v1
https://doi.org/10.21203/rs.3.rs-50333/v1
Autor:
Bauer, Sebastian, Serrano, C., Mehren, M. von, George, S., Heinrich, M. C., Kang, Y.-K., Schöffski, P., Cassier, P. A., Mir, O., Eskens, F., Rutkowski, P., Tap, W., Roche, M., Jones, R. L.
weitere Verfasser ausserhalb der UDE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=unidue___bib::102ac31bed3c804f5f13ae4716af269a
Autor:
Kang, Y.-K., Jones, R. L., von Mehren, M., Serrano, C., George, S., Heinrich, M. C., Schöffski, P., Mir, O., Cassier, P. A., Eskens, F., Rutkowski, P., Tap, W. D., Chawla, S. P., Shi, H., Roche, M., Bauer, Sebastian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=unidue___bib::4a1040f413cdc1be375f79e8fcae9ae7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Levy, S., Aarts, M. J. B., Eskens, F., Keymeulen, K. B. M., Been, L. B., GrUnhagen, D. J., van Akkooi, A. C. J., Jalving, M., Tesselaar, M.
Publikováno v:
Annals of Oncology, 30, 537-538. Oxford University Press
Neuroendocrinology, 110, 232-232. KARGER
Neuroendocrinology, 110, 232-232. KARGER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bcff361cd372dc555bf3c0b2550aa95a
https://research.rug.nl/en/publications/e0c8dd14-ac3a-448d-9d5e-f4e81800f7f7
https://research.rug.nl/en/publications/e0c8dd14-ac3a-448d-9d5e-f4e81800f7f7
Autor:
Banerji, U, Van Herpen, CML, Saura, C, Thistlethwaite, F, Lord, S, Moreno, V, Macpherson, IR, Boni, V, Rolfo, C, De Vries, E, Rottey, S, Geenen, J, Eskens, F, Gil-Martin, M, Mommers, EC, Koper, NP, Aftimos, P, Cox, AJ
Publikováno v:
The Lancet Oncology. 20(8)
Background: Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate comprised of trastuzumab covalently bound to a linker-drug containing duocarmycin. Preclinical studies showed impressive antitumour activity in various models. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::0ed211760a2f5cfd5921d0fd7b3815cd
http://ora.ox.ac.uk/objects/uuid:
http://ora.ox.ac.uk/objects/uuid:
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S758-S758
Autor:
Eskens, F A L M1, Tresca, P2, Tosi, D2, Van Doorn, L1, Fontaine, H3, Van der Gaast, A1, Veyrat-Follet, C4, Oprea, C3, Hospitel, M5, Dieras, V2
Publikováno v:
British Journal of Cancer. 4/29/2014, Vol. 110 Issue 9, p2170-2177. 8p.